events.economist.com
Open in
urlscan Pro
2606:4700:4400::ac40:9b53
Public Scan
Submitted URL: https://mkto-ab220141.com/NzUzLVJJUS00MzgAAAGRSlM5x-fI5_47wJjmx37KoE34Xdr5zculqvDOmXBwAdTvPfwZoZH2oWblY4zBmuInEFc1qUY=
Effective URL: https://events.economist.com/cell-gene-therapy/?RefID=econ_web_cgt24&utm_source=onesites&utm_medium=email&utm_campaign=health...
Submission: On February 15 via api from DE — Scanned from DE
Effective URL: https://events.economist.com/cell-gene-therapy/?RefID=econ_web_cgt24&utm_source=onesites&utm_medium=email&utm_campaign=health...
Submission: On February 15 via api from DE — Scanned from DE
Form analysis
2 forms found in the DOMPOST
<form id="sponsor-form" method="post">
<div class="select-field">
<select id="salutation" name="salutation" class="salutation">
<option value="" selected="selected">- Please Select Salutation -</option>
<option value="Dr.">Dr.</option>
<option value="Mr.">Mr.</option>
<option value="Mrs.">Mrs.</option>
<option value="Ms.">Ms.</option>
<option value="Mx.">Mx.</option>
</select>
</div>
<div class="text-field text-margin">
<input type="text" placeholder="First Name" name="first_name" value="" class="text-input first-name" id="first_name" maxlength="100">
</div>
<div class="text-field">
<input type="text" placeholder="Last Name" name="last_name" value="" class="text-input last-name" id="last_name" maxlength="100">
</div>
<div class="text-field text-margin">
<input type="text" placeholder="Job Title" name="job_title" class="text-input job-title" id="job_title" maxlength="100">
</div>
<div class="text-field">
<input type="text" placeholder="Company" name="company_name" value="" class="text-input company" id="company_name" maxlength="100">
</div>
<div class="select-field">
<select id="industry" name="industry" class="industry">
<option value="">-- Please Select Industry --</option>
<option value="Academia & Education">Academia & Education</option>
<option value="Advertising">Advertising</option>
<option value="Agriculture, Forestry & Fishing">Agriculture, Forestry & Fishing</option>
<option value="Associations & Charities">Associations & Charities</option>
<option value="Chemicals/Mining">Chemicals/Mining</option>
<option value="Communications">Communications</option>
<option value="Construction">Construction</option>
<option value="Financial Services">Financial Services</option>
<option value="Government, NGO & Local Authorities">Government, NGO & Local Authorities</option>
<option value="Healthcare, Pharmaceuticals">Healthcare, Pharmaceuticals</option>
<option value="Information Technology">Information Technology</option>
<option value="Manufacturing">Manufacturing</option>
<option value="Media">Media</option>
<option value="Oil & Gas">Oil & Gas</option>
<option value="Other">Other</option>
<option value="Professional Services">Professional Services</option>
<option value="Recreational Services & Sport">Recreational Services & Sport</option>
<option value="Retail">Retail</option>
<option value="Student / Unemployed">Student / Unemployed</option>
<option value="Trade Unions">Trade Unions</option>
<option value="Transport">Transport</option>
<option value="Travel, Tourism & Hospitality">Travel, Tourism & Hospitality</option>
<option value="Utilities">Utilities</option>
</select>
</div>
<div class="select-field">
<select id="country" name="country" class="country">
<option value="">-- Please Select Country --</option>
<option value="Afghanistan">Afghanistan</option>
<option value="Albania">Albania</option>
<option value="Algeria">Algeria</option>
<option value="American Samoa">American Samoa</option>
<option value="Andorra">Andorra</option>
<option value="Angola">Angola</option>
<option value="Anguilla">Anguilla</option>
<option value="Antarctica">Antarctica</option>
<option value="Antigua & Barbuda">Antigua & Barbuda</option>
<option value="Argentina">Argentina</option>
<option value="Armenia">Armenia</option>
<option value="Aruba">Aruba</option>
<option value="Ascension Island">Ascension Island</option>
<option value="Australia">Australia</option>
<option value="Austria">Austria</option>
<option value="Azerbaijan">Azerbaijan</option>
<option value="Bahamas">Bahamas</option>
<option value="Bahrain">Bahrain</option>
<option value="Bangladesh">Bangladesh</option>
<option value="Barbados">Barbados</option>
<option value="Belarus">Belarus</option>
<option value="Belgium">Belgium</option>
<option value="Belize">Belize</option>
<option value="Benin">Benin</option>
<option value="Bermuda">Bermuda</option>
<option value="Bhutan">Bhutan</option>
<option value="Bolivia">Bolivia</option>
<option value="Bosnia & Herzegovina">Bosnia & Herzegovina</option>
<option value="Botswana">Botswana</option>
<option value="Brazil">Brazil</option>
<option value="Brunei">Brunei</option>
<option value="Bulgaria">Bulgaria</option>
<option value="Burkina Faso">Burkina Faso</option>
<option value="Burundi">Burundi</option>
<option value="Cambodia">Cambodia</option>
<option value="Cameroon">Cameroon</option>
<option value="Canada">Canada</option>
<option value="Cape Verde">Cape Verde</option>
<option value="Cayman Islands">Cayman Islands</option>
<option value="Central African Republic">Central African Republic</option>
<option value="Chad">Chad</option>
<option value="Chile">Chile</option>
<option value="China">China</option>
<option value="Christmas Island">Christmas Island</option>
<option value="Cocos Islands">Cocos Islands</option>
<option value="Colombia">Colombia</option>
<option value="Comoros">Comoros</option>
<option value="Congo">Congo</option>
<option value="Congo (Dem Rep of)">Congo (Dem Rep of)</option>
<option value="Cook Islands">Cook Islands</option>
<option value="Costa Rica">Costa Rica</option>
<option value="Croatia">Croatia</option>
<option value="Cuba">Cuba</option>
<option value="Cyprus">Cyprus</option>
<option value="Czech Republic">Czech Republic</option>
<option value="Denmark">Denmark</option>
<option value="Djibouti">Djibouti</option>
<option value="Dominica">Dominica</option>
<option value="Dominican Republic">Dominican Republic</option>
<option value="East Timor">East Timor</option>
<option value="Ecuador">Ecuador</option>
<option value="Egypt">Egypt</option>
<option value="El Salvador">El Salvador</option>
<option value="Equatorial Guinea">Equatorial Guinea</option>
<option value="Eritrea">Eritrea</option>
<option value="Estonia">Estonia</option>
<option value="Ethiopia">Ethiopia</option>
<option value="Falkland Islands">Falkland Islands</option>
<option value="Faroe Islands">Faroe Islands</option>
<option value="Fiji">Fiji</option>
<option value="Finland">Finland</option>
<option value="France">France</option>
<option value="French Guiana">French Guiana</option>
<option value="French Polynesia">French Polynesia</option>
<option value="French Southern Territories">French Southern Territories</option>
<option value="Gabon">Gabon</option>
<option value="Gambia">Gambia</option>
<option value="Georgia">Georgia</option>
<option value="Germany">Germany</option>
<option value="Ghana">Ghana</option>
<option value="Gibraltar">Gibraltar</option>
<option value="Greece">Greece</option>
<option value="Greenland">Greenland</option>
<option value="Grenada">Grenada</option>
<option value="Guadeloupe">Guadeloupe</option>
<option value="Guam">Guam</option>
<option value="Guatemala">Guatemala</option>
<option value="Guinea">Guinea</option>
<option value="Guinea-Bissau">Guinea-Bissau</option>
<option value="Guyana">Guyana</option>
<option value="Haiti">Haiti</option>
<option value="Honduras">Honduras</option>
<option value="Hong Kong">Hong Kong</option>
<option value="Hungary">Hungary</option>
<option value="Iceland">Iceland</option>
<option value="India">India</option>
<option value="Indonesia">Indonesia</option>
<option value="Iran">Iran</option>
<option value="Iraq">Iraq</option>
<option value="Ireland">Ireland</option>
<option value="Israel">Israel</option>
<option value="Italy">Italy</option>
<option value="Ivory Coast">Ivory Coast</option>
<option value="Jamaica">Jamaica</option>
<option value="Japan">Japan</option>
<option value="Jordan">Jordan</option>
<option value="Kazakhstan">Kazakhstan</option>
<option value="Kenya">Kenya</option>
<option value="Kiribati">Kiribati</option>
<option value="Korea (North)">Korea (North)</option>
<option value="Korea (South)">Korea (South)</option>
<option value="Kosovo">Kosovo</option>
<option value="Kuwait">Kuwait</option>
<option value="Kyrgyzstan">Kyrgyzstan</option>
<option value="Laos">Laos</option>
<option value="Latvia">Latvia</option>
<option value="Lebanon">Lebanon</option>
<option value="Lesotho">Lesotho</option>
<option value="Liberia">Liberia</option>
<option value="Libya">Libya</option>
<option value="Liechtenstein">Liechtenstein</option>
<option value="Lithuania">Lithuania</option>
<option value="Luxembourg">Luxembourg</option>
<option value="Macao">Macao</option>
<option value="Macedonia">Macedonia</option>
<option value="Madagascar">Madagascar</option>
<option value="Malawi">Malawi</option>
<option value="Malaysia">Malaysia</option>
<option value="Maldives">Maldives</option>
<option value="Mali">Mali</option>
<option value="Malta">Malta</option>
<option value="Marshall Islands">Marshall Islands</option>
<option value="Martinique">Martinique</option>
<option value="Mauritania">Mauritania</option>
<option value="Mauritius">Mauritius</option>
<option value="Mayotte">Mayotte</option>
<option value="Mexico">Mexico</option>
<option value="Micronesia (Fed States of)">Micronesia (Fed States of)</option>
<option value="Moldova">Moldova</option>
<option value="Monaco">Monaco</option>
<option value="Mongolia">Mongolia</option>
<option value="Montenegro">Montenegro</option>
<option value="Montserrat">Montserrat</option>
<option value="Morocco">Morocco</option>
<option value="Mozambique">Mozambique</option>
<option value="Myanmar">Myanmar</option>
<option value="Namibia">Namibia</option>
<option value="Nauru">Nauru</option>
<option value="Nepal">Nepal</option>
<option value="Netherlands">Netherlands</option>
<option value="Netherlands Antilles">Netherlands Antilles</option>
<option value="New Caledonia">New Caledonia</option>
<option value="New Zealand">New Zealand</option>
<option value="Nicaragua">Nicaragua</option>
<option value="Niger">Niger</option>
<option value="Nigeria">Nigeria</option>
<option value="Niue">Niue</option>
<option value="Norfolk Island">Norfolk Island</option>
<option value="Northern Mariana Islands">Northern Mariana Islands</option>
<option value="Norway">Norway</option>
<option value="Oman">Oman</option>
<option value="Pakistan">Pakistan</option>
<option value="Palau">Palau</option>
<option value="Palestinian Territory">Palestinian Territory</option>
<option value="Panama">Panama</option>
<option value="Papua New Guinea">Papua New Guinea</option>
<option value="Paraguay">Paraguay</option>
<option value="Peru">Peru</option>
<option value="Philippines">Philippines</option>
<option value="Poland">Poland</option>
<option value="Portugal">Portugal</option>
<option value="Puerto Rico">Puerto Rico</option>
<option value="Qatar">Qatar</option>
<option value="Reunion">Reunion</option>
<option value="Romania">Romania</option>
<option value="Russian Federation">Russian Federation</option>
<option value="Rwanda">Rwanda</option>
<option value="Samoa">Samoa</option>
<option value="Sao Tome & Principe">Sao Tome & Principe</option>
<option value="Saudi Arabia">Saudi Arabia</option>
<option value="Senegal">Senegal</option>
<option value="Serbia">Serbia</option>
<option value="Seychelles">Seychelles</option>
<option value="Sierra Leone">Sierra Leone</option>
<option value="Singapore">Singapore</option>
<option value="Slovakia">Slovakia</option>
<option value="Slovenia">Slovenia</option>
<option value="Solomon Islands">Solomon Islands</option>
<option value="Somalia">Somalia</option>
<option value="South Africa">South Africa</option>
<option value="Spain">Spain</option>
<option value="Sri Lanka">Sri Lanka</option>
<option value="St Helena">St Helena</option>
<option value="St Kitts & Nevis">St Kitts & Nevis</option>
<option value="St Lucia">St Lucia</option>
<option value="St Martin">St Martin</option>
<option value="St Pierre & Miquelon">St Pierre & Miquelon</option>
<option value="St Vincent & the Grenadines">St Vincent & the Grenadines</option>
<option value="Sudan">Sudan</option>
<option value="Suriname">Suriname</option>
<option value="Swaziland">Swaziland</option>
<option value="Sweden">Sweden</option>
<option value="Switzerland">Switzerland</option>
<option value="Syria">Syria</option>
<option value="Taiwan">Taiwan</option>
<option value="Tajikistan">Tajikistan</option>
<option value="Tanzania">Tanzania</option>
<option value="Thailand">Thailand</option>
<option value="Togo">Togo</option>
<option value="Tonga">Tonga</option>
<option value="Trinidad & Tobago">Trinidad & Tobago</option>
<option value="Tristan da Cunha">Tristan da Cunha</option>
<option value="Tunisia">Tunisia</option>
<option value="Turkey">Turkey</option>
<option value="Turkmenistan">Turkmenistan</option>
<option value="Turks & Caicos Islands">Turks & Caicos Islands</option>
<option value="Tuvalu">Tuvalu</option>
<option value="Uganda">Uganda</option>
<option value="Ukraine">Ukraine</option>
<option value="United Arab Emirates">United Arab Emirates</option>
<option value="United Kingdom">United Kingdom</option>
<option value="United States">United States</option>
<option value="Uruguay">Uruguay</option>
<option value="Uzbekistan">Uzbekistan</option>
<option value="Vanuatu">Vanuatu</option>
<option value="Venezuela">Venezuela</option>
<option value="Vietnam">Vietnam</option>
<option value="Virgin Islands (British)">Virgin Islands (British)</option>
<option value="Virgin Islands (US)">Virgin Islands (US)</option>
<option value="Western Sahara">Western Sahara</option>
<option value="Yemen">Yemen</option>
<option value="Zambia">Zambia</option>
<option value="Zimbabwe">Zimbabwe</option>
</select>
</div>
<div class="text-field text-margin">
<input placeholder="Work Email" name="email" value="" class="text-input email" id="email" type="email" maxlength="50">
</div>
<div class="text-field">
<input type="text" placeholder="Work Phone" name="phone_number" class="text-input phone-number" id="phone_number" minlength="8" maxlength="20">
</div>
<div class="select-field">
<select id="interest" name="interest" class="interest">
<option value="">-- What are you interested in? --</option>
<option value="Speaking at the event">Speaking at the event</option>
<option value="Sponsoring this event">Sponsoring this event</option>
<option value="Registering as an attendee">Registering as an attendee</option>
<option value="PR partnership">PR partnership</option>
</select>
</div>
<div class="form-description">
<p class="description-title">Economist Impact is a part of The Economist Group.</p>
<p>We would love to keep you informed about other Economist events, newly-released content, our best subscription offers and great new product offerings.</p>
</div>
<div class="select-field">
<select id="sponsoring-email-opt-in-box" name="teg_email_opt_in" class="email-opt-in">
<option value="">-- I wish to be contacted by email. --</option>
<option value="Yes">Yes</option>
<option value="No">No</option>
</select>
</div>
<!-- <div data-sitekey="" class="g-recaptcha custom-recaptcha" id="sponsor-recapcha"></div> -->
<div class="submit">
<input type="submit" name="submit" id="sponsor-submit">
<span class="ajax-loader hide-loading">
<img src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E" alt="loading-icon"
data-lazy-src="https://events.economist.com/cell-gene-therapy/wp-content/themes/Economist-Events-2021/assets/images/ajax-loader.gif"><noscript><img
src="https://events.economist.com/cell-gene-therapy/wp-content/themes/Economist-Events-2021/assets/images/ajax-loader.gif" alt="loading-icon"></noscript>
</span>
<span class="failure">Something went wrong try again later</span>
</div>
<div class="policy-information">
<p>The Economist Group is a global organisation and operates a strict privacy policy around the world. Please see our privacy policy
<a href="https://www.economistgroup.com/results_and_governance/governance/privacy?RefID=econ_web_cgt24" title="Privacy Policy" target="_blank">here</a></p>
</div>
<input type="hidden" name="sfdc_campaign_id" value="">
<input type="hidden" name="utm_campaign" value="">
<input type="hidden" name="utm_medium" value="">
<input type="hidden" name="utm_source" value="">
<input type="hidden" name="redirect_url" value="https://events.economist.com/cell-gene-therapy">
<input type="hidden" name="event_name" value="Cell and Gene Therapy Summit">
<input type="hidden" name="elqFormName" value="events_sponsor_data_integration">
<input type="hidden" name="elqSiteID" value="2689">
</form>
Name: WebsiteEconomistImpactEvents_brochure_download — POST
<form method="post" name="WebsiteEconomistImpactEvents_brochure_download" id="form3926" class="elq-form">
<input value="WebsiteEconomistImpactEvents_brochure_download" type="hidden" name="elqFormName">
<input value="2689" type="hidden" name="elqSiteId">
<input name="elqCampaignId" type="hidden">
<div id="formElement0" class="elq-field-style select-field">
<select class="elq-item-select salutation" id="fe44849" name="salutation" style="width:100%;" data-value="">
<option value="" selected="selected">- Please Select Salutation -</option>
<option value="Dr.">Dr.</option>
<option value="Mr.">Mr.</option>
<option value="Mrs.">Mrs.</option>
<option value="Ms.">Ms.</option>
<option value="Mx.">Mx.</option>
<option value="Prof.">Prof.</option>
</select>
</div>
<div id="formElement1" class="elq-field-style text-field text-margin">
<input type="text" class="elq-item-input first-name text-input" placeholder="First Name" name="first_name" id="fe44811" value="" style="width:100%;">
</div>
<div id="formElement2" class="elq-field-style text-field">
<input type="text" class="elq-item-input text-input last-name" name="last_name" placeholder="Last Name" id="fe44812" value="" style="width:100%;">
</div>
<div id="formElement3" class="elq-field-style text-field text-margin">
<input type="text" class="elq-item-input text-input job-title" name="job_title" placeholder="Job Title" id="fe44813" value="" style="width:100%;">
</div>
<div id="formElement4" class="elq-field-style text-field">
<input type="text" class="elq-item-input text-input company" name="company" placeholder="Company" id="fe44814" value="" style="width:100%;">
</div>
<div id="formElement5" class="elq-field-style select-field">
<select class="elq-item-select industry" id="fe44850" name="industry" style="width:100%;" data-value="">
<option value="">-- Please Select Industry --</option>
<option value="Academia & Education">Academia & Education</option>
<option value="Advertising">Advertising</option>
<option value="Agriculture, Forestry & Fishing">Agriculture, Forestry & Fishing</option>
<option value="Associations & Charities">Associations & Charities</option>
<option value="Chemicals/Mining">Chemicals/Mining</option>
<option value="Communications">Communications</option>
<option value="Construction">Construction</option>
<option value="Financial Services">Financial Services</option>
<option value="Government, NGO & Local Authorities">Government, NGO & Local Authorities</option>
<option value="Healthcare, Pharmaceuticals">Healthcare, Pharmaceuticals</option>
<option value="Information Technology">Information Technology</option>
<option value="Manufacturing">Manufacturing</option>
<option value="Media">Media</option>
<option value="Oil & Gas">Oil & Gas</option>
<option value="Other">Other</option>
<option value="Professional Services">Professional Services</option>
<option value="Recreational Services & Sport">Recreational Services & Sport</option>
<option value="Retail">Retail</option>
<option value="Student / Unemployed">Student / Unemployed</option>
<option value="Trade Unions">Trade Unions</option>
<option value="Transport">Transport</option>
<option value="Travel, Tourism & Hospitality">Travel, Tourism & Hospitality</option>
<option value="Utilities">Utilities</option>
</select>
</div>
<div id="formElement6" class="elq-field-style select-field">
<select class="elq-item-select country" id="fe44851" name="country" style="width:100%;" data-value="">
<option value="">-- Please Select Country --</option>
<option value="Afghanistan">Afghanistan</option>
<option value="Albania">Albania</option>
<option value="Algeria">Algeria</option>
<option value="American Samoa">American Samoa</option>
<option value="Andorra">Andorra</option>
<option value="Angola">Angola</option>
<option value="Anguilla">Anguilla</option>
<option value="Antarctica">Antarctica</option>
<option value="Antigua and Barbuda">Antigua and Barbuda</option>
<option value="Argentina">Argentina</option>
<option value="Armenia">Armenia</option>
<option value="Aruba">Aruba</option>
<option value="Ascension Island">Ascension Island</option>
<option value="Australia">Australia</option>
<option value="Austria">Austria</option>
<option value="Azerbaijan">Azerbaijan</option>
<option value="Bahamas">Bahamas</option>
<option value="Bahrain">Bahrain</option>
<option value="Bangladesh">Bangladesh</option>
<option value="Barbados">Barbados</option>
<option value="Belarus">Belarus</option>
<option value="Belgium">Belgium</option>
<option value="Belize">Belize</option>
<option value="Benin">Benin</option>
<option value="Bermuda">Bermuda</option>
<option value="Bhutan">Bhutan</option>
<option value="Bolivia">Bolivia</option>
<option value="Bosnia & Herzegovina">Bosnia & Herzegovina</option>
<option value="Botswana">Botswana</option>
<option value="Brazil">Brazil</option>
<option value="Brunei">Brunei</option>
<option value="Bulgaria">Bulgaria</option>
<option value="Burkina Faso">Burkina Faso</option>
<option value="Burundi">Burundi</option>
<option value="Cambodia">Cambodia</option>
<option value="Cameroon">Cameroon</option>
<option value="Canada">Canada</option>
<option value="Cape Verde">Cape Verde</option>
<option value="Cayman Islands">Cayman Islands</option>
<option value="Central African Republic">Central African Republic</option>
<option value="Chad">Chad</option>
<option value="Chile">Chile</option>
<option value="China">China</option>
<option value="Christmas Island">Christmas Island</option>
<option value="Cocos (Keeling) Islands">Cocos (Keeling) Islands</option>
<option value="Colombia">Colombia</option>
<option value="Comoros">Comoros</option>
<option value="Congo">Congo</option>
<option value="Congo, The Democratic Republic">Congo, The Democratic Republic</option>
<option value="Cook Islands">Cook Islands</option>
<option value="Costa Rica">Costa Rica</option>
<option value="Croatia">Croatia</option>
<option value="Cuba">Cuba</option>
<option value="Cyprus">Cyprus</option>
<option value="Czech Republic">Czech Republic</option>
<option value="Denmark">Denmark</option>
<option value="Djibouti">Djibouti</option>
<option value="Dominica">Dominica</option>
<option value="Dominican Republic">Dominican Republic</option>
<option value="East Timor">East Timor</option>
<option value="Ecuador">Ecuador</option>
<option value="Egypt">Egypt</option>
<option value="El Salvador">El Salvador</option>
<option value="Equatorial Guinea">Equatorial Guinea</option>
<option value="Eritrea">Eritrea</option>
<option value="Estonia">Estonia</option>
<option value="Ethiopia">Ethiopia</option>
<option value="Falkland Islands (Malvinas)">Falkland Islands (Malvinas)</option>
<option value="Faroe Islands">Faroe Islands</option>
<option value="Fiji">Fiji</option>
<option value="Finland">Finland</option>
<option value="France">France</option>
<option value="French Guiana">French Guiana</option>
<option value="French Polynesia">French Polynesia</option>
<option value="French Southern Territories">French Southern Territories</option>
<option value="Gabon">Gabon</option>
<option value="Gambia">Gambia</option>
<option value="Georgia">Georgia</option>
<option value="Germany">Germany</option>
<option value="Ghana">Ghana</option>
<option value="Gibraltar">Gibraltar</option>
<option value="Greece">Greece</option>
<option value="Greenland">Greenland</option>
<option value="Grenada">Grenada</option>
<option value="Guadeloupe">Guadeloupe</option>
<option value="Guam">Guam</option>
<option value="Guatemala">Guatemala</option>
<option value="Guinea">Guinea</option>
<option value="Guinea-Bissau">Guinea-Bissau</option>
<option value="Guyana">Guyana</option>
<option value="Haiti">Haiti</option>
<option value="Honduras">Honduras</option>
<option value="Hong Kong">Hong Kong</option>
<option value="Hungary">Hungary</option>
<option value="Iceland">Iceland</option>
<option value="India">India</option>
<option value="Indonesia">Indonesia</option>
<option value="Iran">Iran</option>
<option value="Iraq">Iraq</option>
<option value="Ireland">Ireland</option>
<option value="Israel">Israel</option>
<option value="Italy">Italy</option>
<option value="Ivory Coast">Ivory Coast</option>
<option value="Jamaica">Jamaica</option>
<option value="Japan">Japan</option>
<option value="Jordan">Jordan</option>
<option value="Kazakhstan">Kazakhstan</option>
<option value="Kenya">Kenya</option>
<option value="Kiribati">Kiribati</option>
<option value="Korea (North)">Korea (North)</option>
<option value="Korea (South)">Korea (South)</option>
<option value="Kosovo">Kosovo</option>
<option value="Kuwait">Kuwait</option>
<option value="Kyrgyzstan">Kyrgyzstan</option>
<option value="Lao People's Democratic Rep">Lao People's Democratic Rep</option>
<option value="Latvia">Latvia</option>
<option value="Lebanon">Lebanon</option>
<option value="Lesotho">Lesotho</option>
<option value="Liberia">Liberia</option>
<option value="Libya">Libya</option>
<option value="Liechtenstein">Liechtenstein</option>
<option value="Lithuania">Lithuania</option>
<option value="Luxembourg">Luxembourg</option>
<option value="Macao">Macao</option>
<option value="Macedonia">Macedonia</option>
<option value="Madagascar">Madagascar</option>
<option value="Malawi">Malawi</option>
<option value="Malaysia">Malaysia</option>
<option value="Maldives">Maldives</option>
<option value="Mali">Mali</option>
<option value="Malta">Malta</option>
<option value="Marshall Islands">Marshall Islands</option>
<option value="Martinique">Martinique</option>
<option value="Mauritania">Mauritania</option>
<option value="Mauritius">Mauritius</option>
<option value="Mayotte">Mayotte</option>
<option value="Mexico">Mexico</option>
<option value="Micronesia, Federated States">Micronesia, Federated States</option>
<option value="Moldova">Moldova</option>
<option value="Monaco">Monaco</option>
<option value="Mongolia">Mongolia</option>
<option value="Montenegro">Montenegro</option>
<option value="Montserrat">Montserrat</option>
<option value="Morocco">Morocco</option>
<option value="Mozambique">Mozambique</option>
<option value="Myanmar">Myanmar</option>
<option value="Namibia">Namibia</option>
<option value="Nauru">Nauru</option>
<option value="Nepal">Nepal</option>
<option value="Netherlands">Netherlands</option>
<option value="Netherlands Antilles">Netherlands Antilles</option>
<option value="New Caledonia">New Caledonia</option>
<option value="New Zealand">New Zealand</option>
<option value="Nicaragua">Nicaragua</option>
<option value="Niger">Niger</option>
<option value="Nigeria">Nigeria</option>
<option value="Niue">Niue</option>
<option value="Norfolk Island">Norfolk Island</option>
<option value="Northern Mariana Islands">Northern Mariana Islands</option>
<option value="Norway">Norway</option>
<option value="Oman">Oman</option>
<option value="Pakistan">Pakistan</option>
<option value="Palau">Palau</option>
<option value="Palestinian Territory">Palestine</option>
<option value="Panama">Panama</option>
<option value="Papua New Guinea">Papua New Guinea</option>
<option value="Paraguay">Paraguay</option>
<option value="Peru">Peru</option>
<option value="Philippines">Philippines</option>
<option value="Poland">Poland</option>
<option value="Portugal">Portugal</option>
<option value="Puerto Rico">Puerto Rico</option>
<option value="Qatar">Qatar</option>
<option value="Reunion">Reunion</option>
<option value="Romania">Romania</option>
<option value="Russian Federation">Russian Federation</option>
<option value="Rwanda">Rwanda</option>
<option value="Samoa">Samoa</option>
<option value="Sao Tome and Principe">Sao Tome and Principe</option>
<option value="Saudi Arabia">Saudi Arabia</option>
<option value="Senegal">Senegal</option>
<option value="Serbia">Serbia</option>
<option value="Seychelles">Seychelles</option>
<option value="Sierra Leone">Sierra Leone</option>
<option value="Singapore">Singapore</option>
<option value="Slovakia">Slovakia</option>
<option value="Slovenia">Slovenia</option>
<option value="Solomon Islands">Solomon Islands</option>
<option value="Somalia">Somalia</option>
<option value="South Africa">South Africa</option>
<option value="Spain">Spain</option>
<option value="Sri Lanka">Sri Lanka</option>
<option value="Saint Helena">Saint Helena</option>
<option value="Saint Kitts and Nevis">Saint Kitts and Nevis</option>
<option value="St Lucia">St Lucia</option>
<option value="Saint Martin (French Part)">Saint Martin (French Part)</option>
<option value="Saint Pierre and Miquelon">Saint Pierre and Miquelon</option>
<option value="St Vincent and the Grenadines">St Vincent and the Grenadines</option>
<option value="Sudan">Sudan</option>
<option value="Suriname">Suriname</option>
<option value="Swaziland">Swaziland</option>
<option value="Sweden">Sweden</option>
<option value="Switzerland">Switzerland</option>
<option value="Syria">Syria</option>
<option value="Taiwan">Taiwan</option>
<option value="Tajikistan">Tajikistan</option>
<option value="Tanzania">Tanzania</option>
<option value="Thailand">Thailand</option>
<option value="Togo">Togo</option>
<option value="Tonga">Tonga</option>
<option value="Trinidad & Tobago">Trinidad & Tobago</option>
<option value="Tristan da Cunha">Tristan da Cunha</option>
<option value="Tunisia">Tunisia</option>
<option value="Turkey">Turkey</option>
<option value="Turkmenistan">Turkmenistan</option>
<option value="Turks and Caicos Islands">Turks and Caicos Islands</option>
<option value="Tuvalu">Tuvalu</option>
<option value="Uganda">Uganda</option>
<option value="Ukraine">Ukraine</option>
<option value="United Arab Emirates">United Arab Emirates</option>
<option value="United Kingdom">United Kingdom</option>
<option value="United States">United States</option>
<option value="Uruguay">Uruguay</option>
<option value="Uzbekistan">Uzbekistan</option>
<option value="Vanuatu">Vanuatu</option>
<option value="Venezuela">Venezuela</option>
<option value="Vietnam">Vietnam</option>
<option value="Virgin Islands (British)">Virgin Islands (British)</option>
<option value="Virgin Islands (U.S.)">Virgin Islands (U.S.)</option>
<option value="Western Sahara">Western Sahara</option>
<option value="Yemen">Yemen</option>
<option value="Zambia">Zambia</option>
<option value="Zimbabwe">Zimbabwe</option>
</select>
</div>
<!-- done -->
<div id="formElement7" class="elq-field-style text-field text-margin">
<input type="text" placeholder="Work Email" class="elq-item-input text-input email" name="email" id="fe44815" value="" style="width:100%;">
</div>
<div id="formElement8" class="elq-field-style text-field">
<input type="text" placeholder="Work Phone" class="elq-item-input text-input phone-number" name="phone" id="fe44852" value="" style="width:100%;">
</div>
<div id="formElement9" class="elq-field-style form-description">
<h4 class="elq-heading form-element-form-text description-title">Economist Impact is a part of the Economist Group.</h4>
<p class="form-element-instruction">We would love to keep you informed about other Economist events, newly-released content, our best subscription offers, and great new product offerings from The Economist Group.</p>
</div>
<div id="formElement10" class="elq-field-style select-field">
<select class="elq-item-select email-opt-in" id="fe44817" name="teg_email_opt_in" style="width:100%;" data-value="">
<option value="">-- I wish to be contacted by email: --</option>
<option value="Yes">Yes</option>
<option value="No">No</option>
</select>
</div>
<div id="formElement11" class="elq-field-style">
<div>
<input type="submit" name="submit" id="register-submit" value="Submit">
<span class="ajax-loader hide-loading">
<img src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E" alt="loading-icon"
data-lazy-src="https://events.economist.com/cell-gene-therapy/wp-content/themes/Economist-Events-2021/assets/images/ajax-loader.gif"><noscript><img
src="https://events.economist.com/cell-gene-therapy/wp-content/themes/Economist-Events-2021/assets/images/ajax-loader.gif" alt="loading-icon"></noscript>
</span>
<span class="failure">Something went wrong try again later</span>
</div>
</div>
<input type="hidden" name="source" id="fe49437" value="WEB - Download brochure (Events Website)">
<input type="hidden" name="sfdc_campaign_id" id="fe49438" value="">
<input type="hidden" name="sfdc_campaign_member_status" id="fe49439" value="">
<input type="hidden" name="utm_campaign" id="fe49440" value="">
<input type="hidden" name="utm_medium" id="fe49441" value="">
<input type="hidden" name="utm_source" id="fe49442" value="">
<input type="hidden" name="RefID" id="fe49443" value="">
<input type="hidden" name="redirect_url" id="fe49444" value="https://events.economist.com/cell-gene-therapy">
<input type="hidden" name="event_name" id="fe49445" value="Cell and Gene Therapy Summit">
</form>
Text Content
bar1 bar2 bar3 Menu * Home * Agenda * Speakers * Sponsors * Why sponsor? * About * Event Information * Plan your trip * 2023 Highlights * FAQs * Event brochure * Register - Delegate Pass * Become a sponsor 2ND ANNUAL CELL AND GENE THERAPY SUMMIT Innovation. Access. Progress. April 15th-16th 2024 • Radisson Collection Hotel, Brussels Register now Become a sponsor * 60 + speakers * 25 + content rich-sessions * 300 + attendees CELL AND GENE THERAPIES WILL RESHAPE HEALTHCARE—BUT WHEN? With advances in technology and many innovative treatments on the horizon, cell and gene therapies can reshape healthcare, giving hope to patients who previously had no therapeutic options. But when will their potential be fully realised? Under the stewardship of The Economist’s editorial team, this event will convene industry leaders and healthcare stakeholders to debate the challenges of introducing advanced therapies into the mainstream. It will discuss changes in regulatory landscapes, delivery models, structuring clinical trials and gathering real-world evidence that can improve patient access while ensuring companies maintain a competitive edge. Join industry leaders and healthcare stakeholders in discussing barriers to advancing these innovative therapies and how to improve patient access. * AGENDA * SPEAKERS * SPONSORS SPEAKERS INCLUDE Previous View Profile DAVID BARRETT President, American Society of Gene & Cell Therapy X DAVID BARRETT President, American Society of Gene & Cell Therapy View Profile CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health X CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health Claire Booth is a gene therapist and paediatric immunologist at UCL Great Ormond Street Hospital Institute of Child Health in London, where she leads the clinical stem cell gene therapy programme. Her lab group develops novel therapies for immune-system disorders using both gene therapy/gene editing and targeted small molecules. She is an elected board member of the European Society of Gene and Cell Therapy, chair of the International Committee of the American Society of Gene and Cell Therapy, and co-founder of the AGORA initiative (Access to Gene therapies fOr Rare disease). View Profile ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) X ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) Alexander Natz is secretary-general of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels. He advises innovative pharmaceutical and biotech companies, including startups, in regulatory, pricing and reimbursement matters from the perspective of EU law and German law. From 2008 to 2013 Mr Natz was head of the Brussels office of Bundesverband der Pharmazeutischen Industrie (BPI). Before this he worked at Sträter, a German law firm, with a focus on managed-entry agreements and the licensing of pharmaceuticals. He has also worked in the field of competition law with the European Commission and in the pharmaceutical industry. View Profile MATT BROWN Chief scientific officer, Genomics England X MATT BROWN Chief scientific officer, Genomics England Matt Brown is a clinician-scientist who trained initially in medicine and rheumatology and later in the genetics of ankylosing spondylitis. After teaching musculoskeletal sciences at Oxford University he returned to Australia in 2005 and worked at the University of Queensland, and from 2016 at Queensland University of Technology, where he was professor and director of genomics. In 2019 Dr Brown moved to King’s College London and Guy’s and St Thomas’ Hospitals NHS Trust to direct the NIHR Biomedical Research Centre, and in 2021 he became chief scientific officer of Genomics England. He continues to practise rheumatology and works in cancer genomics and personalised medicine. View Profile ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) X ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) Elisabetta Zanon has been director of EU public affairs and advocacy at the Alliance for Regenerative Medicine since 2021, with responsibility for government relations. She has more than 20 years’ experience in European affairs, including working for EU associations and representing public-sector organisations to EU institutions. Ms Zanon established the National Health Service (NHS) European Office in Brussels at the end of 2007 and led it for ten years. In 2018 she joined the European Society of Cardiology as advocacy director, taking responsibility for the society’s activities in advocacy, regulatory affairs, patient engagement and EU-funded projects. View Profile PETER MARKS Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration X PETER MARKS Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies. Dr. Marks and center staff are committed to facilitating the development of biological products and providing oversight throughout the product life cycle. Examples of these activities include: * reviewing and providing advice during product development * evaluating applications and making approval decisions based on safety and effectiveness data * monitoring the safety of biological products * conducting research that supports product development and characterization “The center regulates and does research on complex biologic products that touch people’s lives on a daily basis,” says Dr. Marks. “Many of the products that we regulate are vital for promoting and protecting the public health, including vaccines, blood products, and tissues for transplantation. I’m very proud to lead a team of highly committed individuals whose efforts help to ensure the timely development of safe and effective products to meet important medical needs.” Dr. Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University. Following this, he completed an Internal Medicine residency and Hematology/Medical Oncology fellowship at Brigham and Women’s Hospital in Boston, where he subsequently joined the attending staff as a clinician-scientist and eventually served as Clinical Director of Hematology. He then moved on to work for several years in the pharmaceutical industry on the clinical development of hematology and oncology products prior to returning to academic medicine at Yale University where he led the Adult Leukemia Service and served as Chief Clinical Officer of Smilow Cancer Hospital. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in 2016. Dr. Marks is board certified in internal medicine, hematology and medical oncology, and is a Fellow of the American College of Physicians. In 2022, he became a Member of the National Academy of Medicine, one of the highest honors in the fields of health, science and medicine. View Profile CHRIS FEARNE Deputy prime minister and minister for European funds, social dialogue and consumer protection, Malta X CHRIS FEARNE Deputy prime minister and minister for European funds, social dialogue and consumer protection, Malta Christopher Fearne was appointed minister for health for Malta in 2016, having been parliamentary secretary for health for the previous two years. In 2017 he was elected deputy prime minister following the Malta Labour Party’s extraordinary general council. After the general elections in March 2022 he was again re-appointed minister for health and deputy prime minister. Mr Fearne was previously a consultant paediatric surgeon and clinical chairman at Mater Dei Hospital. He worked and studied at several children’s hospitals in England, including Great Ormond Street Hospital in London. View Profile HUGUES MALONNE Chief executive, Federal Agency for Medicines and Healthcare Products X HUGUES MALONNE Chief executive, Federal Agency for Medicines and Healthcare Products Hugues Malonne is director-general for pre-authorisation at the Federal Agency for Medicines and Healthcare Products in Brussels. He took this position after a five-year assignment as director general for post-authorisation. Before joining public service Mr Malonne worked on market access and public policy in Europe and Asia for the pharmaceutical industry. He has held academic positions at the University of Brussels and is currently visiting professor at the Université Libre de Bruxelles and the University of Namur. From 2013 to 2019 he was a board member of the Integrated Biobank of Luxembourg and the Luxembourg Institute of Health. View Profile DAVID BARRETT President, American Society of Gene & Cell Therapy X DAVID BARRETT President, American Society of Gene & Cell Therapy View Profile CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health X CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health Claire Booth is a gene therapist and paediatric immunologist at UCL Great Ormond Street Hospital Institute of Child Health in London, where she leads the clinical stem cell gene therapy programme. Her lab group develops novel therapies for immune-system disorders using both gene therapy/gene editing and targeted small molecules. She is an elected board member of the European Society of Gene and Cell Therapy, chair of the International Committee of the American Society of Gene and Cell Therapy, and co-founder of the AGORA initiative (Access to Gene therapies fOr Rare disease). View Profile ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) X ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) Alexander Natz is secretary-general of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels. He advises innovative pharmaceutical and biotech companies, including startups, in regulatory, pricing and reimbursement matters from the perspective of EU law and German law. From 2008 to 2013 Mr Natz was head of the Brussels office of Bundesverband der Pharmazeutischen Industrie (BPI). Before this he worked at Sträter, a German law firm, with a focus on managed-entry agreements and the licensing of pharmaceuticals. He has also worked in the field of competition law with the European Commission and in the pharmaceutical industry. View Profile MATT BROWN Chief scientific officer, Genomics England X MATT BROWN Chief scientific officer, Genomics England Matt Brown is a clinician-scientist who trained initially in medicine and rheumatology and later in the genetics of ankylosing spondylitis. After teaching musculoskeletal sciences at Oxford University he returned to Australia in 2005 and worked at the University of Queensland, and from 2016 at Queensland University of Technology, where he was professor and director of genomics. In 2019 Dr Brown moved to King’s College London and Guy’s and St Thomas’ Hospitals NHS Trust to direct the NIHR Biomedical Research Centre, and in 2021 he became chief scientific officer of Genomics England. He continues to practise rheumatology and works in cancer genomics and personalised medicine. View Profile ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) X ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) Elisabetta Zanon has been director of EU public affairs and advocacy at the Alliance for Regenerative Medicine since 2021, with responsibility for government relations. She has more than 20 years’ experience in European affairs, including working for EU associations and representing public-sector organisations to EU institutions. Ms Zanon established the National Health Service (NHS) European Office in Brussels at the end of 2007 and led it for ten years. In 2018 she joined the European Society of Cardiology as advocacy director, taking responsibility for the society’s activities in advocacy, regulatory affairs, patient engagement and EU-funded projects. View Profile PETER MARKS Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration X PETER MARKS Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies. Dr. Marks and center staff are committed to facilitating the development of biological products and providing oversight throughout the product life cycle. Examples of these activities include: * reviewing and providing advice during product development * evaluating applications and making approval decisions based on safety and effectiveness data * monitoring the safety of biological products * conducting research that supports product development and characterization “The center regulates and does research on complex biologic products that touch people’s lives on a daily basis,” says Dr. Marks. “Many of the products that we regulate are vital for promoting and protecting the public health, including vaccines, blood products, and tissues for transplantation. I’m very proud to lead a team of highly committed individuals whose efforts help to ensure the timely development of safe and effective products to meet important medical needs.” Dr. Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University. Following this, he completed an Internal Medicine residency and Hematology/Medical Oncology fellowship at Brigham and Women’s Hospital in Boston, where he subsequently joined the attending staff as a clinician-scientist and eventually served as Clinical Director of Hematology. He then moved on to work for several years in the pharmaceutical industry on the clinical development of hematology and oncology products prior to returning to academic medicine at Yale University where he led the Adult Leukemia Service and served as Chief Clinical Officer of Smilow Cancer Hospital. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in 2016. Dr. Marks is board certified in internal medicine, hematology and medical oncology, and is a Fellow of the American College of Physicians. In 2022, he became a Member of the National Academy of Medicine, one of the highest honors in the fields of health, science and medicine. View Profile CHRIS FEARNE Deputy prime minister and minister for European funds, social dialogue and consumer protection, Malta X CHRIS FEARNE Deputy prime minister and minister for European funds, social dialogue and consumer protection, Malta Christopher Fearne was appointed minister for health for Malta in 2016, having been parliamentary secretary for health for the previous two years. In 2017 he was elected deputy prime minister following the Malta Labour Party’s extraordinary general council. After the general elections in March 2022 he was again re-appointed minister for health and deputy prime minister. Mr Fearne was previously a consultant paediatric surgeon and clinical chairman at Mater Dei Hospital. He worked and studied at several children’s hospitals in England, including Great Ormond Street Hospital in London. View Profile HUGUES MALONNE Chief executive, Federal Agency for Medicines and Healthcare Products X HUGUES MALONNE Chief executive, Federal Agency for Medicines and Healthcare Products Hugues Malonne is director-general for pre-authorisation at the Federal Agency for Medicines and Healthcare Products in Brussels. He took this position after a five-year assignment as director general for post-authorisation. Before joining public service Mr Malonne worked on market access and public policy in Europe and Asia for the pharmaceutical industry. He has held academic positions at the University of Brussels and is currently visiting professor at the Université Libre de Bruxelles and the University of Namur. From 2013 to 2019 he was a board member of the Integrated Biobank of Luxembourg and the Luxembourg Institute of Health. View Profile DAVID BARRETT President, American Society of Gene & Cell Therapy X DAVID BARRETT President, American Society of Gene & Cell Therapy View Profile CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health X CLAIRE BOOTH Professor of gene therapy and pediatric immunology, UCL GOS Institute of Child Health Claire Booth is a gene therapist and paediatric immunologist at UCL Great Ormond Street Hospital Institute of Child Health in London, where she leads the clinical stem cell gene therapy programme. Her lab group develops novel therapies for immune-system disorders using both gene therapy/gene editing and targeted small molecules. She is an elected board member of the European Society of Gene and Cell Therapy, chair of the International Committee of the American Society of Gene and Cell Therapy, and co-founder of the AGORA initiative (Access to Gene therapies fOr Rare disease). View Profile ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) X ALEXANDER NATZ Secretary-general, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) Alexander Natz is secretary-general of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels. He advises innovative pharmaceutical and biotech companies, including startups, in regulatory, pricing and reimbursement matters from the perspective of EU law and German law. From 2008 to 2013 Mr Natz was head of the Brussels office of Bundesverband der Pharmazeutischen Industrie (BPI). Before this he worked at Sträter, a German law firm, with a focus on managed-entry agreements and the licensing of pharmaceuticals. He has also worked in the field of competition law with the European Commission and in the pharmaceutical industry. View Profile MATT BROWN Chief scientific officer, Genomics England X MATT BROWN Chief scientific officer, Genomics England Matt Brown is a clinician-scientist who trained initially in medicine and rheumatology and later in the genetics of ankylosing spondylitis. After teaching musculoskeletal sciences at Oxford University he returned to Australia in 2005 and worked at the University of Queensland, and from 2016 at Queensland University of Technology, where he was professor and director of genomics. In 2019 Dr Brown moved to King’s College London and Guy’s and St Thomas’ Hospitals NHS Trust to direct the NIHR Biomedical Research Centre, and in 2021 he became chief scientific officer of Genomics England. He continues to practise rheumatology and works in cancer genomics and personalised medicine. View Profile ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) X ELISABETTA ZANON Director of EU policy affairs and advocacy, Alliance for Regenerative Medicine (ARM) Elisabetta Zanon has been director of EU public affairs and advocacy at the Alliance for Regenerative Medicine since 2021, with responsibility for government relations. She has more than 20 years’ experience in European affairs, including working for EU associations and representing public-sector organisations to EU institutions. Ms Zanon established the National Health Service (NHS) European Office in Brussels at the end of 2007 and led it for ten years. In 2018 she joined the European Society of Cardiology as advocacy director, taking responsibility for the society’s activities in advocacy, regulatory affairs, patient engagement and EU-funded projects. Next View the full speaker list here CORE TOPICS INCLUDE: Previous REAL-WORLD EVIDENCE: GETTING THE BEST DATA? AI4CGT: POSSIBLE OR PIPEDREAM? THE POTENTIAL OF CRISPR MODERNISING PAYMENT MODELS FOR CGTS GIVING PATIENTS THEIR VOICE REAL-WORLD EVIDENCE: GETTING THE BEST DATA? AI4CGT: POSSIBLE OR PIPEDREAM? THE POTENTIAL OF CRISPR MODERNISING PAYMENT MODELS FOR CGTS GIVING PATIENTS THEIR VOICE REAL-WORLD EVIDENCE: GETTING THE BEST DATA? AI4CGT: POSSIBLE OR PIPEDREAM? THE POTENTIAL OF CRISPR Next RECEIVE A 15% DISCOUNT CODE FOR YOUR DELEGATE PASS Download our event brochure and join industry stakeholders in discussing barriers to advancing these innovative therapies. Find out more “A great experience! Key stakeholders, expertise and experience present all along the 2-day event. A unique opportunity for networking and meeting with new people from different horizons.” “A fantastic inaugural event which has really laid the foundation for more essential debate, global collaboration and valuable networking ahead in this life changing sector.” “Intellectually stimulating with many great opportunities to engage with fascinating and knowledgeable people from the field. On the organisational side, I was impressed by the smooth communication and proactiveness of the team. Congratulations and I look forward to the next edition!” “Hearing such a breadth of stakeholders voice their belief that we are on the cusp of a medical revolution, gives me real hope that gene therapy will provide a paradigm shift in healthcare for rare diseases I.E. Sickle Cell Disease, improving the lives of so many people across the globe.” “I’m very happy that I had the opportunity to attend this event. It consisted in a strong program and very high level speakers with well managed and engaging moderation and ample time for networking.” “A great experience! Key stakeholders, expertise and experience present all along the 2-day event. A unique opportunity for networking and meeting with new people from different horizons.” “A fantastic inaugural event which has really laid the foundation for more essential debate, global collaboration and valuable networking ahead in this life changing sector.” “Intellectually stimulating with many great opportunities to engage with fascinating and knowledgeable people from the field. On the organisational side, I was impressed by the smooth communication and proactiveness of the team. Congratulations and I look forward to the next edition!” “Hearing such a breadth of stakeholders voice their belief that we are on the cusp of a medical revolution, gives me real hope that gene therapy will provide a paradigm shift in healthcare for rare diseases I.E. Sickle Cell Disease, improving the lives of so many people across the globe.” “I’m very happy that I had the opportunity to attend this event. It consisted in a strong program and very high level speakers with well managed and engaging moderation and ample time for networking.” “A great experience! Key stakeholders, expertise and experience present all along the 2-day event. A unique opportunity for networking and meeting with new people from different horizons.” * 1 * 2 * 3 * 4 * 5 FEATURED SPONSORS: PLATINUM SPONSOR View Profile X PLATINUM SPONSOR JOHNSON & JOHNSON Visit website At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. SILVER SPONSOR View Profile X SILVER SPONSOR CENCORA Visit website Cencora fosters a positive impact on healthcare around the world by providing integrated solutions to strategically guide, deliver, and support cell and gene therapies in market, globally. WHO SHOULD ATTEND? * Industry (Pharmaceutical companies, Biotechnology, etc), * MedTech, * Digital tech providers, * Consultants, * Healthcare providers (private & NHS), * Insurers, * Contract Research Organisations, * Contract development and manufacturing organisations, * Contract manufacturing organisations, * Technical advisory, * Supply Chain Logistics, * Members of parliament, * Government, * Policy, * Charity, * NGO/Non-profits * Academia/researchers, * Patient advocacy groups, * Clinical, * Regulators, * Investors VENUE Radisson Collection Hotel, Grand Place Brussels, Rue du Fossé aux Loups, Brussels, Belgium RELATED EVENTS FUTURE OF HEALTH EUROPE Building a sustainable, inclusive and digital health system November 2024 Europe’s healthcare leaders are under increasin.. Visit website 10TH ANNUAL WORLD CANCER SERIES EUROPE Improving lives through transformative prevention, care and cures September 30th-1st October 2024 • Marriott Hotel Grand P.. Visit website × SPONSORSHIP OPPORTUNITIES Please submit the form and we will reach out to you with more information. Thank you for submitting your details. A member of our team will reach out to you at earliest. - Please Select Salutation - Dr. Mr. Mrs. Ms. Mx. -- Please Select Industry -- Academia & Education Advertising Agriculture, Forestry & Fishing Associations & Charities Chemicals/Mining Communications Construction Financial Services Government, NGO & Local Authorities Healthcare, Pharmaceuticals Information Technology Manufacturing Media Oil & Gas Other Professional Services Recreational Services & Sport Retail Student / Unemployed Trade Unions Transport Travel, Tourism & Hospitality Utilities -- Please Select Country -- Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua & Barbuda Argentina Armenia Aruba Ascension Island Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia & Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos Islands Colombia Comoros Congo Congo (Dem Rep of) Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea (North) Korea (South) Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia (Fed States of) Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Samoa Sao Tome & Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka St Helena St Kitts & Nevis St Lucia St Martin St Pierre & Miquelon St Vincent & the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad & Tobago Tristan da Cunha Tunisia Turkey Turkmenistan Turks & Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (US) Western Sahara Yemen Zambia Zimbabwe -- What are you interested in? -- Speaking at the event Sponsoring this event Registering as an attendee PR partnership Economist Impact is a part of The Economist Group. We would love to keep you informed about other Economist events, newly-released content, our best subscription offers and great new product offerings. -- I wish to be contacted by email. -- Yes No Something went wrong try again later The Economist Group is a global organisation and operates a strict privacy policy around the world. Please see our privacy policy here × DOWNLOAD BROCHURE Please submit the form and we will reach out to you with more information. Thank you for showing interest in the event. We will reach out to you with more information on the registration process. - Please Select Salutation - Dr. Mr. Mrs. Ms. Mx. Prof. -- Please Select Industry -- Academia & Education Advertising Agriculture, Forestry & Fishing Associations & Charities Chemicals/Mining Communications Construction Financial Services Government, NGO & Local Authorities Healthcare, Pharmaceuticals Information Technology Manufacturing Media Oil & Gas Other Professional Services Recreational Services & Sport Retail Student / Unemployed Trade Unions Transport Travel, Tourism & Hospitality Utilities -- Please Select Country -- Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Ascension Island Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia & Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, The Democratic Republic Cook Islands Costa Rica Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea (North) Korea (South) Kosovo Kuwait Kyrgyzstan Lao People's Democratic Rep Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Samoa Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Saint Helena Saint Kitts and Nevis St Lucia Saint Martin (French Part) Saint Pierre and Miquelon St Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad & Tobago Tristan da Cunha Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Western Sahara Yemen Zambia Zimbabwe ECONOMIST IMPACT IS A PART OF THE ECONOMIST GROUP. We would love to keep you informed about other Economist events, newly-released content, our best subscription offers, and great new product offerings from The Economist Group. -- I wish to be contacted by email: -- Yes No Something went wrong try again later * Upcoming events * Past events * About us * Become a sponsor * Economist Group’s – ESG policy * Code of conduct KEEP UPDATED * * * * * * THE ECONOMIST GROUP * The Economist * EuroFinance * The Economist Group * Commercial Payments International * Accessibility * Privacy * Cookie policy * Term to use * Manage Cookie Preferences Copyright @ The Economist Newspaper Limited 2024 All rights reserved × ×